palladium has been researched along with Triple Negative Breast Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jang, ES; Jeong, MS; Manivasagan, P; Saravanakumar, K; Sathiyaseelan, A; Wang, MH | 1 |
| Diniz, C; Ferreira, IMPLVO; Marques, MPM; Mota-Filipe, H; Vojtek, M | 1 |
| Batista de Carvalho, ALM; Batista de Carvalho, LAE; Cinque, G; Dopplapudi, A; García Sakai, V; Gardner, P; Mamede, AP; Marques, MPM; Santos, IP; Wolna, M | 1 |
1 review(s) available for palladium and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
Anticancer activity of palladium-based complexes against triple-negative breast cancer.
Topics: Antineoplastic Agents; Female; Humans; Palladium; Polyamines; Triple Negative Breast Neoplasms | 2019 |
2 other study(ies) available for palladium and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
Folic acid conjugated chitosan encapsulated palladium nanoclusters for NIR triggered photothermal breast cancer treatment.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Chitosan; Drug Carriers; Folic Acid; HEK293 Cells; Humans; Light; Nanoparticles; Palladium; Rutin; Temperature; Triple Negative Breast Neoplasms | 2022 |
Chemotherapeutic Targets in Osteosarcoma: Insights from Synchrotron-MicroFTIR and Quasi-Elastic Neutron Scattering.
Topics: Antineoplastic Agents; Bone Neoplasms; Cisplatin; Fatty Acids; Female; Humans; Neutron Diffraction; Osteosarcoma; Palladium; Spectroscopy, Fourier Transform Infrared; Synchrotrons; Triple Negative Breast Neoplasms; Tumor Cells, Cultured | 2019 |